GlassScriptPhysician profile
Darine A Moukalled
NPI 1982867065
$478.10
in general payments reported to CMS, 2019-2025
12 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2023: $116 · 2024: $56.09 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $128.17 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Aptima |
| Astellas Pharma US INC | $59.59 | 2019-2024 | Veozah |
| Pfizer INC. | $53.41 | 2019 | |
| Optumhealth Care Solutions, LLC | $50.67 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Organon LLC | $36.51 | 2023-2024 | Nexplanon |
| Biogen, INC. | $29.73 | 2025 | Zurzuvae |
| Abbvie INC. | $28.36 | 2019 | |
| Allergan, INC. | $23.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.31 | 2025 | |
| Exeltis, USA INC. | $20.61 | 2024 | Slynd |
| Merck Sharp & Dohme LLC | $14.00 | 2019 | |
| Therapeuticsmd, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darine Moukalled listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.